We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
This paper describes the relationship between obesity and diabetes to support public health policy makers and practitioners.
Further information on what drivers with different types of diabetes need to tell DVLA by law.
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
This document explains the Down’s syndrome screening quality assurance support service (DQASS) and how to use it.
A large study has shown no safety issues of concern relating to the use of metformin during pregnancy. The licence for metformin now reflects that it can be considered for use during pregnancy and the periconceptional phase …
The guidelines emphasise the importance of building strength and balance for adults, and include recommendations for pregnant women, new mothers and disabled people.
Read the software requirements for chance calculation in Down’s syndrome, Edwards’ syndrome and Patau’s syndrome screening, as part of the NHS fetal anomaly screening programme (FASP).
Cutaneous amyloidosis at the injection site has been reported in patients using insulin and this may affect glycaemic control. Remind patients to rotate injection sites within the same body region.
This document sets out guidelines for implementing the NHS diabetic eye screening (DES) programme's surveillance pathways.
Analysis of preconception indicators including wider determinants of health, health behaviours and pre-existing medical conditions.
This guidance explains the management of the cohort (people on the programme register) for the NHS diabetic eye screening (DES) programme.
Analysis of preconception indicators among women who are likely to be migrants including social factors, health behaviours and pre-existing medical conditions.
STFYAYB provides information about the screening tests offered during and after pregnancy.
The Active Hospital feasibility and acceptability pilot explores integrating physical activity interventions in a secondary care setting.
Immunisation information for health professionals and immunisation practitioners.
Use has been restricted to 48 hours’ maximum parenteral use under specialist supervision, after a European safety review.
Employment Tribunal decision.
The Infectious Diseases in Pregnancy Screening Programme's Integrated Screening Outcomes Surveillance Service (ISOSS) 2023 report on pregnancies to women with HIV.
Agenda and minutes for the UK National Screening Committee (UK NSC) meeting on 25 June 2021.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).